Analysis of the 5′ noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France

被引:51
作者
Cantaloube, Jean-Francois
Laperche, Syria
Gallian, Pierre
Bouchardeau, Francoise
de Lamballerie, Xavier
de Micco, Philippe
机构
[1] Etab Francais Sang Alpes Mediterranee, EA3292, Unite Virus Emergents, F-13005 Marseille, France
[2] Inst Natl Transfus Sanguine, F-75015 Paris, France
[3] Univ Mediterranee, Fac Med, Marseille, France
关键词
D O I
10.1128/JCM.02463-05
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The 5' noncoding region (5' NCR) of the hepatitis C virus (HCV) has become the standard for genotyping even though several reports show that its use can result in classification errors. The purpose of this study was to perform genotyping based on sequence analysis of the NS5b region in a set of 357 HCV strains isolated from blood donors in France in 2002 and 2003. Results were compared with those previously obtained using 5' NCR analysis, and HCV subtype distribution was reevaluated. Twenty-six of 120 strains (similar to 22%) initially identified as genotype 1b by 5' NCR region sequence analysis were reclassified as genotype la by NS5b region sequence analysis. Similarly, 14 of 23 strains (similar to 61%) initially identified as 2a/2c were reclassified as non-2a and non-2c subtypes, and 12 of 22 strains (similar to 45%) initially identified as 4c/4d subtypes were reclassified as non-4c and non-4d subtypes. Sequence analysis of the NS5b region also revealed 5 putative new subtype 2 variants and 2 putative new subtype 4 variants. Although these findings demonstrated full agreement between 5' NCR and NS5b sequence analysis with regard to type classification, genotyping based on phylogenetic analysis of the NS5b region is more accurate for subtype determination than genotyping based on analysis of the 5' NCR. Sequence analysis of the NS5b region is mandatory for epidemiologic studies.
引用
收藏
页码:2051 / 2056
页数:6
相关论文
共 40 条
[1]   Epidemiological changes in hepatitis C virus genotypes in France:: evidence in intravenous drug users [J].
Bourlière, M ;
Barberin, JM ;
Rotily, M ;
Guagliardo, V ;
Portal, I ;
Lecomte, L ;
Benali, S ;
Boustière, C ;
Perrier, H ;
Jullien, M ;
Lambot, G ;
Loyer, R ;
LeBars, O ;
Daniel, R ;
Khiri, H ;
Halfon, P .
JOURNAL OF VIRAL HEPATITIS, 2002, 9 (01) :62-70
[2]   Molecular analysis of HCV type 1 to 5 envelope gene: application to investigations of posttransfusion transmission of HCV [J].
Cantaloube, JF ;
Venault, H ;
Zappitelli, JP ;
Gallian, P ;
Touinssi, M ;
Attoui, H ;
Biagini, P ;
de Lamballerie, X ;
de Micco, P .
TRANSFUSION, 2000, 40 (06) :712-717
[3]   Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France [J].
Cantaloube, JF ;
Gallian, P ;
Attoui, H ;
Biagini, P ;
De Micco, P ;
de Lamballerie, X .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) :3624-3629
[4]   Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East [J].
Chamberlain, RW ;
Adams, N ;
Saeed, AA ;
Simmonds, P ;
Elliott, RM .
JOURNAL OF GENERAL VIROLOGY, 1997, 78 :1341-1347
[5]   Hepatitis C virus genotyping:: Interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b [J].
Chen, ZY ;
Weck, KE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) :3127-3134
[6]   GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455
[7]   Hepatitis C virus:: Routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors [J].
Elghouzzi, MH ;
Bouchardeau, F ;
Pillonel, J ;
Boiret, E ;
Tirtaine, C ;
Barlet, V ;
Moncharmont, P ;
Maisonneuve, P ;
du Puy-Montbrun, MC ;
Lyon-Caen, D ;
Couroucé, AM .
VOX SANGUINIS, 2000, 79 (03) :138-144
[8]   Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the amplicor HCV test [J].
Germer, JJ ;
Rys, PN ;
Thorvilson, JN ;
Persing, DH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (08) :2625-2630
[9]   Evaluation of the TRUGENE HCV 5′NC genotyping kit with the new GeneLibrarian module 3.1.2 for genotyping of hepatitis C virus from clinical specimens [J].
Germer, JJ ;
Majewski, DW ;
Rosser, M ;
Thompson, A ;
Mitchell, PS ;
Smith, TF ;
Elagin, S ;
Yao, JDC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) :4855-4857
[10]   Hepatitis C virus genotyping based on 5′ noncoding sequence analysis (Trugene) [J].
Halfon, P ;
Trimoulet, P ;
Bourliere, M ;
Khiri, H ;
de Lédinghen, V ;
Couzigou, P ;
Feryn, JM ;
Alcaraz, P ;
Renou, C ;
Fleury, HJA ;
Ouzan, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) :1771-1773